Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Sphingolipid-induced bone regulation and its emerging role in dysfunction due to disease and infection

Seal, Anouska, Hughes, Megan, Wei, Fei, Pugazhendhi, Abinaya S., Ngo, Christopher, Ruiz, Jonathan, Schwartzman, Jonathan D. and Coathup, Melanie J. 2024. Sphingolipid-induced bone regulation and its emerging role in dysfunction due to disease and infection. International Journal of Molecular Sciences 25 (5) , 3024. 10.3390/ijms25053024

[thumbnail of ijms-25-03024.pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (3MB) | Preview

Abstract

The human skeleton is a metabolically active system that is constantly regenerating via the tightly regulated and highly coordinated processes of bone resorption and formation. Emerging evidence reveals fascinating new insights into the role of sphingolipids, including sphingomyelin, sphingosine, ceramide, and sphingosine-1-phosphate, in bone homeostasis. Sphingolipids are a major class of highly bioactive lipids able to activate distinct protein targets including, lipases, phosphatases, and kinases, thereby conferring distinct cellular functions beyond energy metabolism. Lipids are known to contribute to the progression of chronic inflammation, and notably, an increase in bone marrow adiposity parallel to elevated bone loss is observed in most pathological bone conditions, including aging, rheumatoid arthritis, osteoarthritis, and osteomyelitis. Of the numerous classes of lipids that form, sphingolipids are considered among the most deleterious. This review highlights the important primary role of sphingolipids in bone homeostasis and how dysregulation of these bioactive metabolites appears central to many chronic bone-related diseases. Further, their contribution to the invasion, virulence, and colonization of both viral and bacterial host cell infections is also discussed. Many unmet clinical needs remain, and data to date suggest the future use of sphingolipid-targeted therapy to regulate bone dysfunction due to a variety of diseases or infection are highly promising. However, deciphering the biochemical and molecular mechanisms of this diverse and extremely complex sphingolipidome, both in terms of bone health and disease, is considered the next frontier in the field.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
Publisher: MDPI
ISSN: 1422-0067
Date of First Compliant Deposit: 2 April 2024
Date of Acceptance: 4 March 2024
Last Modified: 04 Apr 2024 13:27
URI: https://orca.cardiff.ac.uk/id/eprint/167643

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics